150 related articles for article (PubMed ID: 7912164)
1. The growth inhibiting effect of docetaxel (Taxotere) in head and neck squamous cell carcinoma xenografts.
Braakhuis BJ; Kegel A; Welters MJ
Cancer Lett; 1994 Jun; 81(2):151-4. PubMed ID: 7912164
[TBL] [Abstract][Full Text] [Related]
2. Docetaxel (Taxotere): an active drug for the treatment of patients with advanced squamous cell carcinoma of the head and neck. EORTC Early Clinical Trials Group.
Catimel G; Verweij J; Mattijssen V; Hanauske A; Piccart M; Wanders J; Franklin H; Le Bail N; Clavel M; Kaye SB
Ann Oncol; 1994 Jul; 5(6):533-7. PubMed ID: 7918125
[TBL] [Abstract][Full Text] [Related]
3. Second-line treatment with docetaxel after failure of a platinum-based chemotherapy in squamous-cell head and neck cancer.
Numico G; Merlano M
Ann Oncol; 2002 Feb; 13(2):331-3. PubMed ID: 11886014
[No Abstract] [Full Text] [Related]
4. Docetaxel in head and neck cancer: a review.
Colevas AD; Posner MR
Am J Clin Oncol; 1998 Oct; 21(5):482-6. PubMed ID: 9781605
[TBL] [Abstract][Full Text] [Related]
5. Docetaxel in squamous cell cancer of the head and neck.
Posner MR
Anticancer Drugs; 2001 Feb; 12 Suppl 1():S21-4. PubMed ID: 11340900
[TBL] [Abstract][Full Text] [Related]
6. Antitumor activity of taxotere (RP 56976, NSC 628503), a new taxol analog, in experimental ovarian cancer.
Boven E; Venema-Gaberscek E; Erkelens CA; Bissery MC; Pinedo HM
Ann Oncol; 1993 Apr; 4(4):321-4. PubMed ID: 8100146
[TBL] [Abstract][Full Text] [Related]
7. Integration of taxanes into primary chemotherapy for squamous cell carcinoma of the head and neck: promise fulfilled?
Brockstein B
Curr Opin Oncol; 2000 May; 12(3):221-8. PubMed ID: 10841194
[TBL] [Abstract][Full Text] [Related]
8. Taxoids in head and neck cancer: the American approach.
Forastiere AA
Acta Otorhinolaryngol Belg; 1999; 53(3):253-7. PubMed ID: 10635404
[TBL] [Abstract][Full Text] [Related]
9. The role of docetaxel in the management of squamous cell cancer of the head and neck.
Glisson BS
Oncology (Williston Park); 2002 Jun; 16(6 Suppl 6):83-7. PubMed ID: 12108901
[TBL] [Abstract][Full Text] [Related]
10. [Experimental chemotherapy of xenotransplanted oral squamous epithelial carcinoma: effectiveness of docetaxel (taxotere) in the nude mouse model].
Hüttmann C; Eckardt A; Fokas K; Haindl J
Mund Kiefer Gesichtschir; 1999 Sep; 3(5):257-62. PubMed ID: 10540826
[TBL] [Abstract][Full Text] [Related]
11. Docetaxel: an active drug for squamous cell carcinoma of the head and neck.
Dreyfuss AI; Clark JR; Norris CM; Rossi RM; Lucarini JW; Busse PM; Poulin MD; Thornhill L; Costello R; Posner MR
J Clin Oncol; 1996 May; 14(5):1672-8. PubMed ID: 8622087
[TBL] [Abstract][Full Text] [Related]
12. [Antitumor effect of docetaxel against human esophagus tumor cell lines and tumor xenografts in nude mice].
Shakuto S; Fujita F; Fujita M
Gan To Kagaku Ryoho; 2006 Mar; 33(3):337-43. PubMed ID: 16531714
[TBL] [Abstract][Full Text] [Related]
13. A phase I trial of weekly docetaxel and cisplatinum combined to concurrent hyperfractionated radiotherapy for non-small cell lung cancer and squamous cell carcinoma of head and neck.
Varveris H; Mazonakis M; Vlachaki M; Kachris S; Lyraraki E; Zoras O; Maris T; Froudarakis M; Velegrakis J; Perysinakis C; Damilakis J; Samonis G
Oncol Rep; 2003; 10(1):185-95. PubMed ID: 12469168
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of antitumour effects of docetaxel (Taxotere) on human gastric cancers in vitro and in vivo.
Tanaka M; Obata T; Sasaki T
Eur J Cancer; 1996 Feb; 32A(2):226-30. PubMed ID: 8664032
[TBL] [Abstract][Full Text] [Related]
15. Small interfering RNA targeting epidermal growth factor receptor enhances chemosensitivity to cisplatin, 5-fluorouracil and docetaxel in head and neck squamous cell carcinoma.
Nozawa H; Tadakuma T; Ono T; Sato M; Hiroi S; Masumoto K; Sato Y
Cancer Sci; 2006 Oct; 97(10):1115-24. PubMed ID: 16984384
[TBL] [Abstract][Full Text] [Related]
16. Antitumor effects of epidermal growth factor receptor antisense oligonucleotides in combination with docetaxel in squamous cell carcinoma of the head and neck.
Niwa H; Wentzel AL; Li M; Gooding WE; Lui VW; Grandis JR
Clin Cancer Res; 2003 Oct; 9(13):5028-35. PubMed ID: 14581378
[TBL] [Abstract][Full Text] [Related]
17. The current status of docetaxel in solid tumors. An M. D. Anderson Cancer Center Review.
Hong WK
Oncology (Williston Park); 2002 Jun; 16(6 Suppl 6):9-15. PubMed ID: 12108903
[TBL] [Abstract][Full Text] [Related]
18. Comparison of paclitaxel and docetaxel activity on human ovarian carcinoma xenografts.
Nicoletti MI; Lucchini V; D'Incalci M; Giavazzi R
Eur J Cancer; 1994; 30A(5):691-6. PubMed ID: 7915909
[TBL] [Abstract][Full Text] [Related]
19. Antitumor efficacy of taxane liposomes on a human ovarian tumor xenograft in nude athymic mice.
Sharma A; Straubinger RM; Ojima I; Bernacki RJ
J Pharm Sci; 1995 Dec; 84(12):1400-4. PubMed ID: 8748320
[TBL] [Abstract][Full Text] [Related]
20. Induction chemotherapy with docetaxel, cisplatin, fluorouracil, and leucovorin for squamous cell carcinoma of the head and neck: a phase I/II trial.
Colevas AD; Busse PM; Norris CM; Fried M; Tishler RB; Poulin M; Fabian RL; Fitzgerald TJ; Dreyfuss A; Peters ES; Adak S; Costello R; Barton JJ; Posner MR
J Clin Oncol; 1998 Apr; 16(4):1331-9. PubMed ID: 9552034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
